Ami Fadia
Stock Analyst at Needham
(4.97)
# 88
Out of 4,792 analysts
637
Total ratings
59.6%
Success rate
35.2%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $310 | $241.31 | +28.47% | 73 | Aug 31, 2026 | |
| MPLT MapLight Therapeutics | Rated: Buy | $45 → $43 | $13.71 | +213.64% | 9 | Aug 31, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $240 → $275 | $207.68 | +32.42% | 36 | Aug 31, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $5 | $1.20 | +316.67% | 21 | Aug 14, 2026 | |
| ACAD ACADIA Pharmaceuticals | Rated: Buy | $38 → $41 | $27.68 | +48.12% | 39 | Aug 12, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $50 → $66 | $37.99 | +73.73% | 11 | Aug 12, 2026 | |
| COGT Cogent Biosciences | Rated: Hold | n/a | $34.18 | - | 28 | Aug 11, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $255 → $268 | $210.63 | +27.24% | 26 | Aug 10, 2026 | |
| GHRS GH Research | Reiterated: Buy | $32 → $39 | $27.56 | +41.51% | 6 | Aug 6, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $575 → $582 | $345.30 | +68.55% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $18 | $4.61 | +290.46% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $50 | $41.62 | +20.13% | 53 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $204 | $155.14 | +31.49% | 44 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $4.01 | +249.56% | 44 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $45.40 | +36.56% | 18 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $256 | $210.73 | +21.48% | 70 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.29 | - | 10 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €108.00 | €78.65 | n/a | 8 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $10.68 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $7.71 | n/a | 2 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $15 | $3.80 | n/a | 3 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.50 | n/a | 6 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $14.34 | n/a | 10 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.5 → $6 | $17.25 | n/a | 9 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $14.39 | n/a | 9 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $75 | $25.88 | n/a | 7 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 5 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $0.00001 | n/a | 3 | Dec 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $24 | $0.333 | n/a | 9 | Dec 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $1.5 | $0.000001 | n/a | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $16.64 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $14 | $36.85 | n/a | 11 | Aug 6, 2020 |
Jazz Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $310
Current: $241.31
Upside: +28.47%
MapLight Therapeutics
Aug 31, 2026
Rated: Buy
Price Target: $45 → $43
Current: $13.71
Upside: +213.64%
Revolution Medicines
Aug 31, 2026
Reiterated: Buy
Price Target: $240 → $275
Current: $207.68
Upside: +32.42%
Neumora Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $1.20
Upside: +316.67%
ACADIA Pharmaceuticals
Aug 12, 2026
Rated: Buy
Price Target: $38 → $41
Current: $27.68
Upside: +48.12%
Definium Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $50 → $66
Current: $37.99
Upside: +73.73%
Cogent Biosciences
Aug 11, 2026
Rated: Hold
Price Target: n/a
Current: $34.18
Upside: -
Axsome Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $255 → $268
Current: $210.63
Upside: +27.24%
GH Research
Aug 6, 2026
Reiterated: Buy
Price Target: $32 → $39
Current: $27.56
Upside: +41.51%
Praxis Precision Medicines
Aug 6, 2026
Reiterated: Buy
Price Target: $575 → $582
Current: $345.30
Upside: +68.55%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $18
Current: $4.61
Upside: +290.46%
Aug 4, 2026
Reiterated: Buy
Price Target: $45 → $50
Current: $41.62
Upside: +20.13%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $204
Current: $155.14
Upside: +31.49%
Jul 30, 2026
Reiterated: Buy
Price Target: $15 → $14
Current: $4.01
Upside: +249.56%
Jul 29, 2026
Reiterated: Buy
Price Target: $62
Current: $45.40
Upside: +36.56%
Jul 29, 2026
Reiterated: Buy
Price Target: $256
Current: $210.73
Upside: +21.48%
Jul 16, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.29
Upside: -
Apr 25, 2025
Reiterated: Buy
Price Target: €108.00
Current: €78.65
Upside: n/a
Dec 14, 2022
Initiated Coverage: Hold
Price Target: n/a
Current: $10.68
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $10 → $7
Current: $7.71
Upside: n/a
Mar 8, 2021
Reiterated: Buy
Price Target: $10 → $15
Current: $3.80
Upside: n/a
Mar 2, 2021
Rated: Hold
Price Target: n/a
Current: $16.50
Upside: n/a
Mar 1, 2021
Rated: Buy
Price Target: $63
Current: $14.34
Upside: n/a
Feb 26, 2021
Rated: Hold
Price Target: $5.5 → $6
Current: $17.25
Upside: n/a
Feb 25, 2021
Rated: Buy
Price Target: $16
Current: $14.39
Upside: n/a
Feb 25, 2021
Rated: Hold
Price Target: $75
Current: $25.88
Upside: n/a
Jan 11, 2021
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Dec 30, 2020
Reiterated: Buy
Price Target: $10 → $7
Current: $0.00001
Upside: n/a
Dec 2, 2020
Reiterated: Buy
Price Target: $19 → $24
Current: $0.333
Upside: n/a
Oct 1, 2020
Reiterated: Hold
Price Target: $1 → $1.5
Current: $0.000001
Upside: n/a
Aug 14, 2020
Reiterated: Buy
Price Target: $8 → $9
Current: $16.64
Upside: n/a
Aug 6, 2020
Reiterated: Hold
Price Target: $12 → $14
Current: $36.85
Upside: n/a